We are live on
!
Find out more
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
ONCE
Delisted
ONCE was delisted on the 16th of December, 2019.
176 hedge funds and large institutions have $2.17B invested in Spark Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 65 increasing their positions, 53 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 53
17% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 23
2% more funds holding
Funds holding: 172 → 176 (+4)
23% less call options, than puts
Call options by funds: $8.35M | Put options by funds: $10.9M
33% less capital invested
Capital invested by funds: $3.23B → $2.17B (-$1.07B)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
176
Holders Change
+4
Holders Change %
+2.33%
% of All Funds
4.02%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
27
Increased
65
Reduced
53
Closed
23
Calls
$8.35M
Puts
$10.9M
Net Calls
-$2.54M
Net Calls Change
+$4.72M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$110M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$57.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$20.8M |
| 4 |
CC
Casdin Capital
New York
|
+$14.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.1M |
Top Sellers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$74.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$50.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.2M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$23.3M |
| 5 |
Morgan Stanley
New York
|
-$20.8M |
